The $200,000 revenue was primarily from the trial with the US Pharrma company, no actual VX patient revenue, however they have said this will be in the March Quarter but as I have noted they have shown any tendency to update us and my assumption is this will be very slow going for now.
Ann: 4DMedical Reports 1H FY22 Results, page-11
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
-0.050(8.77%) |
Mkt cap ! $203.5M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 51.5¢ | $1.080M | 2.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21197 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.5¢ | 4369 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |